Centro Hospitalar De Lisboa Ocidental E.P.E.

The department is conducting research focused on cardiovascular diseases, addressing conditions such as heart failure with preserved ejection fraction and atrial fibrillation. Trials aim to assess new anticoagulant strategies and anti‑inflammatory therapies to reduce stroke risk and improve heart failure outcomes.

• Heart failure with preserved ejection fraction and systemic inflammation
• Anticoagulation therapy for atrial fibrillation to prevent stroke
• Inflammation‑targeted treatment to lower cardiovascular mortality

At Centro Hospitalar De Lisboa Ocidental, five investigators are leading these studies, contributing to advances in cardiovascular care in Lisbon.

The ophthalmology department is engaged in studies on eye diseases, specifically retinopathy of prematurity. The trial evaluates long‑term safety and visual function of a novel treatment for this condition.

• Retinopathy of prematurity long‑term outcomes
• Visual function assessment in premature infants
• Safety monitoring of new ocular therapy

These investigations are carried out at Centro Hospitalar De Lisboa Ocidental, with a team of five clinicians aiming to improve pediatric eye health across Portugal.